Scienmag
AUGUST 20, 2020
GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma Credit: Insilico Medicine August 20th, 2020, Hong Kong – Researchers from Johns Hopkins University in collaboration with Insilico Medicine announce the publication of a new research paper titled “GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma” (..)
pharmaphorum
MAY 27, 2022
This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. data processing systems that support bioinformatics modelling) and digital record systems (e.g. You can read part one of this article here. About the interviewees.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
DECEMBER 10, 2020
Ducks, rats, mice, pigs and chickens had lower or no susceptibility to infection Credit: Javier Delgado Humans, followed by ferrets and to a lesser extent cats, civets and dogs are the most susceptible animals to SARS-CoV-2 infection, according to an analysis of ten different species carried out by researchers at the Centre for Genomic Regulation […]. (..)
Drug Discovery World
APRIL 14, 2023
Carl H June, MD, FAACR – Lifetime Achievement in Cancer Research June, a Fellow of the AACR Academy, is the Richard W Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies, and Director of the Parker Institute for Cancer Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania.
pharmaphorum
APRIL 15, 2021
Collaboration when innovating in areas of high unmet medical need is critical and at Astellas, it means experts with highly specialised knowledge of these new discoveries often work in close partnership with regulators. “We In principle, this goes beyond medicines. It’s through this collaboration that we help shape the future.”.
STAT News
MARCH 6, 2023
It works with commercial partners and researchers at the Washington University School of Medicine in St. Therapeutic vaccines represent the next frontier in cancer medicine. Although the FDA allows drugmakers to charge patients for unproven medicines provided for compassionate use, it’s uncommon and controversial.
Drug Discovery World
JULY 11, 2023
It is also anticipated that the Food and Drug Administration (FDA) and European Medicines Agency (EMA) will provide more guidance on requirements for AI/ML-enabled processes across the pharmaceutical industry as they become more mainstream.
Expert insights. Personalized for you.
52 
Let's personalize your content